[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-369695-105":59,"doc-detail-369695-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","relationship-between-aggregate-index-of-systemic-inflammation-and-mortality-from-ccd-and-malignant-neoplasms-in-diabetic-patients","Relationship between aggregate index of systemic inflammation and mortality from CCD and malignant neoplasms in diabetic patients","","Inflammation is central to diabetes pathophysiology, and the aggregate index of systemic inflammation (AISI) has been proposed as a biomarker for inflammatory status and clinical prognosis. Evidence linking AISI to mortality in diabetic populations remains limited. Using NHANES data (2001–2018), multivariable-adjusted Cox models assessed mortality risk from cardiocerebrovascular disease (CCD) and malignant neoplasms. Elevated AISI predicted higher CCD and malignant neoplasm mortality, supported by Kaplan–Meier and restricted cubic spline analyses, with robustness confirmed by subgroup and sensitivity tests.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/relationship-between-aggregate-index-of-systemic-inflammation-and-mortality-from-ccd-and-malignant-neoplasms-in-diabetic-patients/369695/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/relationship-between-aggregate-index-of-systemic-inflammation-and-mortality-from-ccd-and-malignant-neoplasms-in-diabetic-patients/369695.png","ImageObject",300,407,{"name":92,"@type":93},"Cart","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-30","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the study’s main objective regarding AISI in diabetes?","Question",{"text":112,"@type":113},"To investigate whether the aggregate index of systemic inflammation (AISI) is associated with mortality risk from cardiocerebrovascular disease (CCD) and malignant neoplasms in diabetic patients.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which dataset and time period were used to evaluate the associations?",{"text":117,"@type":113},"The study analyzed NHANES data from nine consecutive cycles covering 2001–2018.",{"name":119,"@type":110,"acceptedAnswer":120},"What statistical methods support the relationship between AISI and mortality?",{"text":121,"@type":113},"Multivariable-adjusted Cox models quantify hazard ratios, Kaplan–Meier curves compare survival across AISI levels, and restricted cubic spline analysis models risk trends; robustness is further checked with subgroup and sensitivity analyses.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},369695,1790817555,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},18829141979164,"https://eur-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nRelationship between aggregate index of systemic inflammation and mortality from CCD and malignant neoplasms in diabetic patients  \nZhihui li1,4, Hua Li1,4, Peng Wang1,4, Wei Xie2, Guo Shao3,5􀀍 & Hongwei Zhu1,5􀀍  \nInflammation has been recognized as a pivotal factor in the pathophysiology of diabetes. The aggregate index of systemic inflammation (AISI) has recently been proposed as a novel biomarker for evaluating inflammatory status and predicting clinical outcomes. However, evidence on the association between AISI and mortality in diabetic patients remains limited. To address this knowledge gap, we aimed to investigate the association between AISI and mortality risk from cardiocerebrovascular disease (CCD) and malignant neoplasms in diabetic patients. We analyzed data from the National Health and Nutrition Examination Survey (NHANES, 2001–2018) . Multivariable-adjusted Cox models revealed strong associations between elevated AISI levels and CCD mortality (HR 1.18, 95% CI 1.11–1.26) as well as malignant neoplasm mortality (HR 1.20, 95% CI 1.10–1.30) . Kaplan–Meier analysis showed that higher AISI was associated with lower survival in diabetic patients for both CCD and malignant neoplasms. Restricted cubic spline (RCS) analysis demonstrated an increased risk of mortality from CCD and malignant neoplasms in diabetic patients with elevated AISI levels. Subgroup and sensitivity analyses confirmed the robustness of these findings. In adults with diabetes, elevated AISI levels are strongly associated with an increased risk of mortality from CCD and malignant neoplasms.  \nKeywords Cardio-cerebrovascular disease (CCD) mortality, Malignant neoplasm mortality, Aggregate indexof systemic inflammation (AISI), Diabetes  \nThe sustained increase in diabetes prevalence represents a significant challenge to global public health1. According to International Diabetes Federation (IDF) projections, approximately 783 million adults aged 20–79 years worldwide will have diabetes by 20452. Cardiovascular disease remains the predominant cause of mortality in diabetic patients3. Improved management of cardiovascular risk factors has revealed malignant neoplasms as an increasingly important contributor to mortality in this population4. Early identification of risk factors is critical for developing targeted interventions to reduce mortality in diabetic patients.  \nChronic low-grade inflammation contributes significantly to diabetes pathogenesis, disease progression, and mortality risk5. The Aggregate Index of Systemic Inflammation (AISI) establishes a novel approach for assessing systemic inflammation through algorithmic integration of multiple hematological parameters. This composite metric demonstrates stronger clinical predictive performance than conventional single-parameter markers6,7. AISI shows clinically meaningful associations with disease progression in hypertension6 and pulmonary fibrosis8. Furthermore, AISI has demonstrated prognostic value for mortality risk in multiple cancers, including prostate9, esophageal10, and gastric11, establishing its potential as a clinically useful inflammatory marker. However, evidence regarding the association between AISI and mortality in diabetic populations remains  \n1The Second Affiliated Hospital of Baotou Medical College, Inner Mongolia University of Science and Technology, Baotou, China. 2Inner Mongolia Key Laboratory of Hypoxic Translational Medicine, Baotou Medical College, Baotou, Inner Mongolia, China. 3Center for Translational Medicine, The Third People’s Hospital of Longgang District, Shenzhen, China. 4Zhihui li, Hua Li and Peng Wang have contributed equally to this work and share first authorship. 5Guo Shao and Hongwei Zhu contributed equally to this work. 􀀍 email: [shao.guo.china@gmail.com](shao.guo.china@gmail.com); [zhwyjs@163.com](zhwyjs@163.com)  \n[www. nature.com/scientificreports/](www. nature.com/scientificrep","cbCaiv5yymZn3FVe","https://ap.wps.com/l/cbCaiv5yymZn3FVe","pdf",2006217,11,"English","# Abstract\n# Introduction\n# Materials and methods\n## Data source and study population\n## Variable selection and follow-up\n# Results\n# Subgroup and sensitivity analyses\n# Discussion","[{\"question\":\"What is the study’s main objective regarding AISI in diabetes?\",\"answer\":\"To investigate whether the aggregate index of systemic inflammation (AISI) is associated with mortality risk from cardiocerebrovascular disease (CCD) and malignant neoplasms in diabetic patients.\"},{\"question\":\"Which dataset and time period were used to evaluate the associations?\",\"answer\":\"The study analyzed NHANES data from nine consecutive cycles covering 2001–2018.\"},{\"question\":\"What statistical methods support the relationship between AISI and mortality?\",\"answer\":\"Multivariable-adjusted Cox models quantify hazard ratios, Kaplan–Meier curves compare survival across AISI levels, and restricted cubic spline analysis models risk trends; robustness is further checked with subgroup and sensitivity analyses.\"}]","Relationship between aggregate index of systemic inflammation and mortality from CCD and malignant neoplasms in diabetic patients | PDF",1790184130,28,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f1fae7feda43f858e4d28348b24ac13d.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1e0ba2c3bf078345a51e16e94a9d261f.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/29a22eec4938bf62dd187126be02f8bf.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/218bb0665fe7f694d13a4e69be1a2e3f.webp",980,1287]